arrow
E

Eiji Shinozaki

cancer institute hospital of japanese foundation for cancer research
H指数:29
被引数:3,475

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用:一项前瞻性单臂II期临床试验

2026-09-090
OAAI
Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study

日本接受 fruquintinib 治疗的转移性结直肠癌患者中,蛋白尿作为早期剂量调整的原因:一项多中心真实世界研究

2026-08-270
OAAI
Cytotoxic immune activity reflects a coordinated immune microenvironment and is associated with response to total neoadjuvant therapy in rectal cancer

细胞毒性免疫活性反映协调的免疫微环境,并与直肠癌中总新辅助治疗的应答相关

2026-08-180
PRE
Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

Zolbetuximab联合化疗在Claudin 18亚型2阳性晚期胃癌中的安全性与有效性:真实世界经验的初步报告

2025-12-180
OAAI
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC

早期较高的血浆瑞戈菲布浓度预示日本结直肠癌患者无进展生存期缩短

2025-11-040
OAAI
Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis

局部晚期直肠癌总新辅助治疗方案对放疗诱导性淋巴细胞减少的影响:一项回顾性分析

2025-11-010
OA
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer

Kinugasa, Y.; Uehara, K.; Yamaguchi, K.; Saito, Y.; Murofushi, K.; Sugai, T.; Ishiguro, M.; Ishihara, S.; Ueno, H.; Oka, S.; 等. 日本结直肠癌协会(JSCCR). 日本结直肠癌协会2024年结直肠癌治疗指南. 国际临床肿瘤学杂志, 2025, 30, 2410–2463. [Google Scholar] [CrossRef]

2025-11-011
PRE
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)

一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究:BRAVERY研究(EPOC1701)

2025-10-090
OAAI
Effect of pretreatment vascular endothelial growth factor inhibitor use on the safety and efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer

使用术前血管内皮生长因子抑制剂的既往用药对三氟尿idine/替吡拉塞联合贝伐珠单抗在转移性结直肠癌患者中安全性与有效性的影响

2025-07-210
PRE
Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma

多西他赛、顺铂和5-氟尿嘧啶新辅助治疗局部晚期食管鳞状细胞癌的真实世界安全性和有效性

2025-04-080
OAAI